SCHEMBL7991108

SCHEMBL7991108

O=CCOc1cccc2cnccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA3 P22001 1/20 0.57
NR3C1 P04150 3/20 0.46
HTT P42858 1/20 0.45
KDM4E B2RXH2 3/20 0.45
LMNA P02545 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
MAPKAPK2 P49137 1/20 0.45
CACNA2D1 P54289 5/20 0.41
ADRB2 P07550 1/20 0.41
ADRB1 P08588 1/20 0.41
ADRB3 P13945 1/20 0.41
MAPK1 P28482 1/20 0.40
NR2F2 P24468 1/20 0.40
RAB9A P51151 1/20 0.40
ERN1 O75460 1/20 0.40
GPBAR1 Q8TDU6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5454024 0.84 KCNA3 (0.57) KCNA3NR3C1HTTKDM4ELMNA
SCHEMBL6604458 0.80 KDM4E (0.56) KCNA3KDM4ECYP1A2CYP2C19ALDH1A1
SCHEMBL94801 0.79 KCNA3 (0.61) KCNA3NR3C1HTTKDM4ELMNA
SCHEMBL14251166 0.79 KCNA3 (0.61) KCNA3NR3C1HTTKDM4ELMNA
SCHEMBL11144866 0.79 KCNA3 (0.61) KCNA3NR3C1HTTKDM4ELMNA
Water SCHEMBL9707280 0.78 KDM4E (0.54) KCNA3KDM4ECYP1A2CYP2C19ALDH1A1
SCHEMBL6283416 0.78 KCNA3 (0.57) KCNA3NR3C1HTTKDM4ELMNA
SCHEMBL7344375 0.77 KDM4E (0.67) KCNA3NR3C1KDM4ELMNACYP1A2
SCHEMBL4763782 0.76 KCNA3 (0.55) KCNA3NR3C1HTTKDM4ELMNA
SCHEMBL5449325 0.76 KCNA3 (0.67) KCNA3NR3C1KDM4ELMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291432-B1 (R)-N-(2-METHYLBENZYL)-3-((2S, 3S)-3-(N-(2-CHROMONECARBONYL)-L-ASPARAGINYL)AMINO-2-HYDROXY-4-PHENYLBUTANO YL)-5,5-DIMETHYL-1,3-THIAZOLIDINE-4-CARBOXAMIDE CAN BE GIVEN AS A TYPICAL EXAMPLE OF THIS COMPOUND. JAPAN ENERGY CORPORATION (JP) 2001-09-18 US disclosed
EP-0900566-A1 NOVEL TRIPEPTIDE COMPOUNDS AND ANTI-AIDS DRUGS JAPAN ENERGY CORPORATION (JP) 1999-03-10 EP disclosed